RE:Interesting Chart Pattern Shows.......The share price rose sharply in mid August after the McMaser Covid research update and Q2, it then over corrected to low 60's (wiping out gains from these 2 great fundamental catalysts), has consolidated between 60 - 70 and has just broken out of the trading range this week.
The catalyst is the use of increased NRC grant towards the large scale industrial mfg of PGX Y-BG at the PGX demo plant to generate product for human clinical trials. I for one would have expected such an annoucment to be met with a flurry of investors piling in.
A muted response from the market so far, that is another sign of in-efficient markets in the nano-cap stock universe. One requisite of efficient markets is dissemination of information and investors reacting accordingly. Absent here for sure.